Healing of serious diseases in vivo is often limited by the inability of the body to rebuild a sufficient amount of healthy cells. Especially in neurons and chondrocytes (cartilaginous tissue) this is a big challenge. One research goal of many stem cell facilities is to understand the molecular mechanisms of diseases like e.g. Parkinson’s disease (PD) or to create models for reconstructive medicine and stem cell therapies. For these scientists, induced pluripotent stem (iPS) cells are a highly valuable tool in their research.
